, Tracking Stock Market Picks
Enter Symbol:
Rating: UNIS
Buy $7.50

Unilife Corporation (NASDAQ: UNIS) rated to Buy with price target $7.50 by Cantor Fitzgerald

Tuesday,  Dec 18, 2012  8:25 AM ET by Betsy O'Brien Harrison

Cantor Fitzgerald rated Unilife
Corporation (NASDAQ: UNIS) to Buy with price target $7.50.

Unilife Corporation engages in the design, development, manufacture, and supply of healthcare safety products for medical device and pharmaceutical industries in Australia and the United States. The company?s products include the Unifill syringe, a ready-to-fill (prefillable) syringe with integrated safety features for injectable drug filling and packaging systems; and clinical and prefilled safety syringes with automatic and controlled needle retraction features. It also provides medical device contract manufacturing services for healthcare and pharmaceutical suppliers. Unilife Corporation is based in Lewisberry, Pennsylvania.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy